Tscan Therapeutics Inc Dividends
The next dividend date for Tscan Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Tscan Therapeutics Inc (TCRX)
More About Tscan Therapeutics Inc
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Owning Tscan Therapeutics Inc Stock on the Dividend Date
If you own Tscan Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Tscan Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Tscan Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Tscan Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Tscan Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Tscan Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about Tscan Therapeutics Inc dividends or anything else related to the stock market.